Great success for the Invest Securities BioMed Event(r) : over 300 participants for this first edition

The "Invest Securities BioMed Event®", launched by Invest Securities last Wednesday, January 27 was greatly successful with over 300 business managers and investors throughout the day.

PARIS, Feb. 1, 2016 (GLOBE NEWSWIRE) -- Organized by CF&B Communication, the event gathered 60 European listed and non-listed companies (French, Swiss, Dutch, Belgian, Spanish.), from the sectors of biotechs, health services, pharmaceuticals and medical techs, who met 135 investors, Fund Managers, Family offices, Private Equity funds.

The day was busy in presentations and exchanges about these companies' development, challenges and the financing of their growth. In particular, over 600 individual meetings with investors were organized.

The first edition of the « Invest Securities BioMed Event® » has demonstrated Invest Securities' expertise in the field of Life Science that is now supported by a dedicated team of 6 experts, analysts and investment bankers.
Over the past months, they have assisted many business from the sectors in their equity capital operations, such as Biophytis, OSE Pharma, Quantum Genomics, Safe Orthopaedics.

Jean-Emmanuel Vernay, Managing Director, Invest Securities, states: "We were really pleased to welcome so many quality companies and to allow for such proximity for them with investors. Communications between players are all the more important nowadays on ever more complex markets. The BioMed Event has become the greatest pan-European event dedicated to Biotechs' financing and we are already thinking of a 2nd edition."

Francis Bader, Chairman, CF&B Communication adds: « We were happy to work again with Invest Securities, and their involvement in the making of the event has been the key to its success. By combining Invest Securities' expertise in Life Science sectors together with CF&B Communication's know-how in designing and producing operations dedicated to the financial industry, we have together managed to make the best of the "Invest Securities BioMed Event®", that is already a major pan-European event."

About Invest Securities (

Invest Securities is an independant financial services group of more than 90 people, created in 2001 that provides full investment banking services through three specialized entities : Invest Securities Corporate ( Corporate finance), Invest Securities société de bourse (an investment services provider approved by Banque de France), Amplégest ( an independent asset management company , oversee 1 Billion Euros of assets). A sum of combined skills allowing to handle any type of long term financing operations (M&A, private equity, equity capital markets).
More than 170 deals since its creation ( Ipo,Public offerings, private placements, trade sales, mergers.). 1st underwriter on the Euronext Paris and Brussels market with 50 IPO's. A high value-added services full broker ( analysis, intermediation, execution), a full range of services for issuers ( corporate broking, liquidity providing, financial analysis, buy-backs, tender offers, roadshows, sales & trading, primary market .) . An independent asset management company ( 610 M€ under asset) founded in 2007 with Invest Securities. A team of 22 people with strong values.

About CF&B Communication (

Specialized in the organization of meetings between listed companies and institutional investors for 17 years in Europe, CF&B Communication holds over 18 events per year in partnership with Stock Exchanges, Brokers, Banks, communications agencies, etc.

For further queries, please contact Thierry ROUSSILHE or Caroline GILLIUME


Source: CF&B Communication